News

points of light

Western medicine often functions more like a high-tech patient-processing machine than a high-touch people-healing mission. This can and must change, argue three distinguished healthcare thought leaders. 

Johnson & Johnson MedTech Impella AIC

The FDA has identified another safety concern with Johnson & Johnson MedTech's Automated Impella Controllers. This comes after the devices were linked to five separate recalls in 2025. 

Cardiologist heart

The Alliance for Aging Research wants CMS to go through with policy changes that could make many more patients eligible for TAVR. The agency is currently considering the changes, and a final decision is expected in June. 

warning safety alert recall healthcare issue

This Class II recall includes more than 18,000 cannulae used during cardiac surgery.

Jupiter Endovascular's Vertex Pulmonary Embolectomy System showed positive results in its SPIRARE II pivotal trial.

"Pulmonary embolism is fundamentally a cardiovascular disease, where restoration of hemodynamic stability, beyond simple clot removal, is the key determinant of patient recovery,” one researcher explained. 

Thumbnail

First revealed in March, the incident was confirmed to be months long. NYC Health + Hospitals blamed the intrusion on an unnamed third-party vendor. Stolen data includes medical records, finger and palm prints, and location data from patients and workers alike.

Thumbnail

HHS Secretary Robert F. Kennedy Jr. is tapping Stephanie Haridopolos, MD, to temporarily fill the role and carry out some of the duties handled by the “nation’s doctor.” 

AI healthcare doctor surgery procedure artificial intelligence

The nation’s largest doc advocacy group made the declaration in a new practice management tool aimed at the growing use of chatbots. 

Nexus Aortic Arch System Artivion Endospan

The purchase price could end up being closer to $200 million if certain commercial milestones are met.

Ziad Ali, MD, DPhil, director of the DeMatteis Cardiovascular Institute, St. Francis Hospital and Heart Center, spoke with Cardiovascular Business about his center's experience using the recently released Johnson & Johnson MedTech next-generation Shockwave C2 Aero Coronary IVL Catheter to treat calcified coronary artery disease. Ali said his center was the first in the world to use the catheter in August 2025 and has since gained experience in roughly 80 cases.

Ziad Ali, MD, said the new device has completely changed the way he and his colleagues treat patients with calcified coronary artery disease. 

breast radiologist breast cancer mammography

The needles were added to the FDA’s list of device shortages in April months after a major manufacturer stopped shipments to “correct an issue."

Medtronic Evolut FX TAVR valve

These three-year data represent a major update to one of the more noteworthy TAVR trials in recent memory.

Around the web

Western medicine often functions more like a high-tech patient-processing machine than a high-touch people-healing mission. This can and must change, argue three distinguished healthcare thought leaders. 

The FDA has identified another safety concern with Johnson & Johnson MedTech's Automated Impella Controllers. This comes after the devices were linked to five separate recalls in 2025. 

The Alliance for Aging Research wants CMS to go through with policy changes that could make many more patients eligible for TAVR. The agency is currently considering the changes, and a final decision is expected in June.